Annual D&A
N/A
December 1, 2024
Summary
- ADPT annual depreciation & amortization is not available.
Performance
ADPT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
December 1, 2024
Summary
- ADPT quarterly depreciation & amortization is not available.
Performance
ADPT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
December 1, 2024
Summary
- ADPT TTM depreciation & amortization is not available.
Performance
ADPT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
ADPT Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
ADPT Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time |
Adaptive Biotechnologies Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $4.59 M(-8.2%) | $20.20 M(-5.5%) |
Jun 2024 | - | $5.00 M(-4.0%) | $21.37 M(-3.0%) |
Mar 2024 | - | $5.21 M(-3.3%) | $22.02 M(-0.9%) |
Dec 2023 | $22.23 M(+6.3%) | $5.39 M(-6.4%) | $22.23 M(+0.5%) |
Sep 2023 | - | $5.76 M(+1.9%) | $22.13 M(+1.7%) |
Jun 2023 | - | $5.65 M(+4.2%) | $21.75 M(+2.2%) |
Mar 2023 | - | $5.42 M(+2.6%) | $21.29 M(+1.8%) |
Dec 2022 | $20.92 M(+49.9%) | $5.29 M(-1.8%) | $20.92 M(+2.1%) |
Sep 2022 | - | $5.38 M(+3.6%) | $20.48 M(+10.0%) |
Jun 2022 | - | $5.20 M(+2.7%) | $18.63 M(+14.0%) |
Mar 2022 | - | $5.06 M(+4.3%) | $16.34 M(+17.1%) |
Dec 2021 | $13.95 M | $4.85 M(+37.4%) | $13.95 M(+21.8%) |
Sep 2021 | - | $3.53 M(+21.4%) | $11.46 M(+13.7%) |
Jun 2021 | - | $2.90 M(+8.8%) | $10.07 M(+9.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | $2.67 M(+13.6%) | $9.16 M(+8.2%) |
Dec 2020 | $8.47 M(+8.7%) | $2.35 M(+9.7%) | $8.47 M(+3.4%) |
Sep 2020 | - | $2.14 M(+7.3%) | $8.20 M(+1.0%) |
Jun 2020 | - | $2.00 M(+1.0%) | $8.11 M(+1.6%) |
Mar 2020 | - | $1.98 M(-4.7%) | $7.99 M(+2.5%) |
Dec 2019 | $7.79 M(+29.8%) | $2.08 M(+0.6%) | $7.79 M(+6.6%) |
Sep 2019 | - | $2.06 M(+10.3%) | $7.31 M(+8.9%) |
Jun 2019 | - | $1.87 M(+4.9%) | $6.71 M(+6.0%) |
Mar 2019 | - | $1.78 M(+11.9%) | $6.33 M(+5.5%) |
Dec 2018 | $6.00 M(+3.5%) | $1.59 M(+8.7%) | $6.00 M(+36.1%) |
Sep 2018 | - | $1.47 M(-1.7%) | $4.41 M(+49.8%) |
Jun 2018 | - | $1.49 M(+2.8%) | $2.94 M(+102.8%) |
Mar 2018 | - | $1.45 M | $1.45 M |
Dec 2017 | $5.80 M | - | - |
FAQ
- What is the all time high annual D&A for Adaptive Biotechnologies?
- What is the all time high quarterly D&A for Adaptive Biotechnologies?
- What is the all time high TTM D&A for Adaptive Biotechnologies?
What is the all time high annual D&A for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual depreciation & amortization is $22.23 M
What is the all time high quarterly D&A for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly depreciation & amortization is $5.76 M
What is the all time high TTM D&A for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM depreciation & amortization is $22.23 M